Clinical trials for cardiac patients.

Sharp offers numerous heart-related clinical trials. These trials are vital to finding and advancing heart treatment options and play a key role in saving the lives of more heart patients.

Research improves lives.

We are currently involved in studies covering the following:

• Coronary artery blockage angioplasty and stenting treatment
• Cardiac medications, such as blood thinners or anticoagulants and their reversal agents
• Use of technology for early detection of subclinical atrial fibrillation/atrial tachyarrhythmia and device malfunction on patients with cardiac implantable electronic devices
• Medication alternatives for the prevention of atrial fibrillation-related strokes
• Nonsurgical treatment options for aortic stenosis
• Use of innovative device to help in the management of heart failure

Enroll in an active cardiac clinical trial.

If you are interested in participating in a clinical trial, please consult with your physician or contact the Sharp Center for Research at 858-939-7198 or send us an email.

• NCT02389946 - coronary artery disease, atherosclerosis, coronary myocardial ischemia, ischemic heart disease, acute coronary syndrome, angina pectoris; sponsored by Biotronik, Inc., study on Orsiro Sirolimus Eluting Coronary Stent System
• NCT02290028 - heart failure; sponsored by Biotronik, Inc., study on Sentus Quadripolar leads (OTW QP L and Sentus OTW QP S) in patients with CRT-D indication
• NCT03155724 – heart failure; sponsored by Biotronik, Inc., study on multipole pacing in CRT non-responders
• NCT03218787 – coronary artery lesion, Dual Antiplatelet Therapy (DAPT); sponsored by Abbott Medical Devices, study on DAPT after XIENCE stent implantation for high bleed risk patients
• NCT02627196 – heart failure, baroreceptors, Baroreflex; sponsored by CVRx, Inc., study on Baroreflex Activation Therapy in patients with heart failure

Learn more about cardiac clinical trials.

To learn more about clinical trials at Sharp, visit the Sharp Center for Research or send us an email.